{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:11:55Z","timestamp":1789049515952,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","ajog.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ajog.2024.04.014","type":"journal-article","created":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T01:39:24Z","timestamp":1713058764000},"page":"330.e1-330.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cost-effectiveness of BRCA1 testing at time of obstetrical prenatal carrier screening for cancer prevention"],"prefix":"10.1016","volume":"231","author":[{"given":"Shayan M.","family":"Dioun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza R.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malavika","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4174-6015","authenticated-orcid":false,"given":"Jesse T.","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad D.","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June Y.","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi N.","family":"Sharaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa K.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2024.04.014_bib1","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/jama.2014.12483","article-title":"Population-based screening for BRCA1 and BRCA2: 2014 Lasker award","volume":"312","author":"King","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2024.04.014_bib2","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2024.04.014_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Dwyer","year":"2021","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.ajog.2024.04.014_bib4","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1\u00a0or BRCA2 mutation carriers with cancer\u00a0risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2024.04.014_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.22874","article-title":"Cost-effectiveness of population-wide genomic screening for hereditary breast and ovarian cancer in the United States","volume":"3","author":"Guzauskas","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajog.2024.04.014_bib6","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1200\/JCO.2017.73.6314","article-title":"National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer","volume":"35","author":"Childers","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2024.04.014_bib7","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1097\/AOG.0000000000001952","volume":"129","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.04.014_bib8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/jgc4.1566","article-title":"Expanded carrier screening in the United States: a systematic evidence review exploring client and provider experiences","volume":"31","author":"Ramdaney","year":"2022","journal-title":"J\u00a0Genet Couns"},{"key":"10.1016\/j.ajog.2024.04.014_bib9","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1200\/JCO.2016.67.0554","article-title":"Population frequency of germline BRCA1\/2 mutations","volume":"34","author":"Maxwell","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2024.04.014_bib10","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/jama.2023.1792","article-title":"Cost-effectiveness thresholds used by study authors, 1990\u20132021","volume":"329","author":"Neumann","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2024.04.014_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2022.2260","article-title":"Evaluating costs associated with genetic counseling among commercially insured US patients with cancer from 2013 to 2019","volume":"3","author":"Roberson","year":"2022","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.ajog.2024.04.014_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ygyno.2017.05.034","article-title":"Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention","volume":"146","author":"Dilley","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2024.04.014_bib14","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1001\/jamaoncol.2019.3323","article-title":"A\u00a0cost-effectiveness analysis of multigene testing for all patients with breast cancer","volume":"5","author":"Sun","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ajog.2024.04.014_bib15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jval.2017.01.006","article-title":"A\u00a0multigene test could cost-effectively help extend life expectancy for women at risk of hereditary breast cancer","volume":"20","author":"Li","year":"2017","journal-title":"Value Health"},{"key":"10.1016\/j.ajog.2024.04.014_bib16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10549-014-3134-0","article-title":"Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers","volume":"148","author":"Chai","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ajog.2024.04.014_bib17","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1200\/JCO.21.02016","article-title":"Risk of peritoneal carcinomatosis after risk-reducing salpingo-oophorectomy: a systematic review and individual patient data meta-analysis","volume":"40","author":"Steenbeek","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2024.04.014_bib19","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/jnci\/djn103","article-title":"Cost of care for elderly cancer patients in the United States","volume":"100","author":"Yabroff","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2024.04.014_bib20","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ygyno.2008.12.026","article-title":"Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment","volume":"113","author":"Havrilesky","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2024.04.014_bib21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ygyno.2020.08.013","article-title":"Cost-effectiveness of laparib as a maintenance treatment for women with newly diagnosed advanced ovarian cancer and BRCA1\/2 mutations in the United States","volume":"159","author":"Muston","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2024.04.014_bib22","series-title":"Vital statistics rapid release births: provisional data for 2021","author":"Hamilton","year":"2022"},{"key":"10.1016\/j.ajog.2024.04.014_bib23","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41436-020-0807-4","article-title":"Clinical experience with carrier screening in a general population: support for a comprehensive pan-ethnic approach","volume":"22","author":"Westemeyer","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.ajog.2024.04.014_bib24","first-page":"1","article-title":"United States life tables, 2020","volume":"71","author":"Arias","year":"2022","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ajog.2024.04.014_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.7326\/M15-1536","article-title":"Collaborative modeling of the benefits and harms associated with different U.S. Breast Cancer Screening Strategies","volume":"164","author":"Mandelblatt","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2024.04.014_bib26","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/1471-0528.16967","article-title":"Minimally invasive surgery for suspected early-stage ovarian cancer; a cost-effectiveness study","volume":"129","author":"Dioun","year":"2022","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2024.04.014_bib27","series-title":"Decision modelling for health economic evaluation","author":"Briggs","year":"2006"},{"key":"10.1016\/j.ajog.2024.04.014_bib28","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/jnci\/dju379","article-title":"Population testing for cancer predisposing BRCA1\/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial","volume":"107","author":"Manchanda","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2024.04.014_bib29","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41436-018-0277-0","article-title":"Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibility","volume":"21","author":"Rowley","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.ajog.2024.04.014_bib30","doi-asserted-by":"crossref","first-page":"14205","DOI":"10.1073\/pnas.1415979111","article-title":"Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2","volume":"111","author":"Gabai-Kapara","year":"2014","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824005209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824005209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T12:43:42Z","timestamp":1724330622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937824005209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0002937824005209"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2024.04.014","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of BRCA1 testing at time of obstetrical prenatal carrier screening for cancer prevention","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2024.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}